This research uses deep learning models to uncover sex-specific survival predictors for high-grade gliomas (HGGs). By ...

In an interview with School of Medicine Dean Dr. Mary Klotman, Dr. David Ashley explains some of the challenges of treating brain tumors and the ...

Executive Vice President for Health Affairs and Dean of the Duke University School of Medicine Mary Klotman talks with David ...

Rigel Pharma surged 50.1% due to strong revenue drivers, strategic partnerships, and undervaluation, justifying a Strong Buy ...

CLD-101 is a novel stem cell-based treatment that delivers oncolytic viruses to tumors, which may benefit patients with newly ...

Georgie Maynard was at home with her youngest kids when she started to feel unwell with a migraine before she blacked out and ...

Researchers at UNIGE and HUG have created CAR-T cells that can selectively target malignant gliomas, sparing the surrounding healthy tissue. Glioblastoma is the most common and aggressive form of ...

Scientists have discovered that a molecule called kalata B1, found in violets, can significantly enhance the effectiveness of the chemotherapy drug Temozolomide (TMZ) in treating glioblastoma.

Violets produce a dazzling suite of small circular peptides called cyclotides. They roughly appear in shape "like floppy frisbees," says Dr. Samantha L. Gerlach. "They have been found active in the ...

A study presented at the American Society for Radiation Oncology on Oct. 1 offers promise for the treatment of high-grade gliomas using Elekta AB’s Unity MR-Linac system.

Glioblastoma is one of the most serious brain diseases known. More than 45% of brain cancers are gliomas. Only half of ...

The following is a summary of “Single-nucleus RNA-sequencing Reveals a MET+ Oligodendrocyte Subpopulation that Promotes ...